⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIOA News
BioAge Labs, Inc. Common Stock
BioArctic publishes the Annual Report and Sustainability Report for 2025 USA - English USA - English
prnewswire.com
BIOA
BioArctic publishes the Annual Report and Sustainability Report for 2025
prnewswire.com
BIOA
BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP
globenewswire.com
BIOA
BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference
globenewswire.com
BIOA
The Nomination Committee's proposal for the election of Board members and Chairperson of the Board in BioArctic AB USA - English USA - English
prnewswire.com
BIOA
Form 8-K
sec.gov
BIOA
New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress
prnewswire.com
BIOA
BIIB
BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
globenewswire.com
BIOA
BLA for subcutaneous formulation of Leqembi® designated for Priority Review in China USA - English USA - English
prnewswire.com
BIOA
BIIB
BLA for subcutaneous formulation of Leqembi® designated for Priority Review in China USA - English USA - English
prnewswire.com
BIOA
BIIB